Paula Cabrera
Impact in
-
- Galectins and Cancer Biology
- Toxin Mechanisms and Immunotoxins
- Immunotherapy and Immune Responses
-
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Immunotherapy and Immune Responses 5
- Galectins and Cancer Biology 2
-
- Glycosylation and Glycoproteins Research 7
- Co-authors
- Guillermo Blanco (6 shared papers)Linda G. Baum (3 shared papers)Silvia E. Hajos (6 shared papers)Élida Álvarez (4 shared papers)Laura Alaniz (3 shared papers)Helena Kaija (1 shared paper)Karen E. Pace (1 shared paper)Katja Porvari (1 shared paper)
- Journals
- Cancer Research (2 papers)Inflammation Research (1 paper)Cell Communication & Adhesion (1 paper)Blood (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- ArgentinaUnited StatesMexico
In The Last Decade
Paula Cabrera
19 papers receiving 258 citations
Peers
Comparison fields: 5 of 65
- Immunology 117
- Cell Biology 52
- Immunology and Allergy 17
- Molecular Biology 162
- Oncology 46
Countries citing papers authored by Paula Cabrera
This map shows the geographic impact of Paula Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Cabrera more than expected).
Fields of papers citing papers by Paula Cabrera
This network shows the impact of papers produced by Paula Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Cabrera. The network helps show where Paula Cabrera may publish in the future.
Co-authors
The 25 scholars most cited alongside Paula Cabrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 70 | |
| 2 | 2002 | 40 | |
| 3 | 2006 | 39 | |
| 4 | 2004 | 30 | |
| 5 | Zymosan modulates CD44 isoform expression in a murine model of inflammation resembling rheumatoid arthritis synovitis. | 2001 | 16 |
| 6 | 2020 | 16 | |
| 7 | 2012 | 14 | |
| 8 | 2004 | 13 | |
| 9 | 2002 | 9 | |
| 10 | [Isoforms modulation of CD44 adhesion molecule in a murine model of ischemia and intestinal reperfusion]. | 2000 | 3 |
| 11 | 2009 | 3 | |
| 12 | 2003 | 2 | |
| 13 | 2018 | 2 | |
| 14 | [Differential binding of hyaluronic acid in 2 CD44+ sublines. Relationship with tumor infiltration]. | 2000 | 2 |
| 15 | 2001 | 1 | |
| 16 | 2018 | 1 | |
| 17 | Unión diferencial de ácido hialurónico en dos sublíneas celulares CD44+: Posible implicancia en la infiltración tumoral | 2000 | 1 |
| 18 | 1985 | 1 | |
| 19 | 1985 | 1 |
About Paula Cabrera
Paula Cabrera is a scholar working on Immunology, Molecular Biology, Cell Biology, Oncology and Genetics, having authored 19 papers that have together received 264 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), Proteoglycans and glycosaminoglycans research (6 papers), Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (3 papers), Galectins and Cancer Biology (2 papers), Cell Adhesion Molecules Research (2 papers), Virus-based gene therapy research (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Immunology (117 citations), Cell Biology (52 citations), Immunology and Allergy (17 citations), Molecular Biology (162 citations) and Oncology (46 citations). Paula Cabrera has collaborated with scholars based in Argentina, United States and Mexico. Frequent co-authors include Guillermo Blanco, Linda G. Baum, Silvia E. Hajos, Élida Álvarez, Laura Alaniz, Helena Kaija, Karen E. Pace, Katja Porvari, Rachel White and Pirkko Vihko. Their work appears in journals such as Cancer Research, Inflammation Research, Cell Communication & Adhesion, Blood and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.